Efficacy and safety of anlotinib combined with transarterial chemoembolization versus transarterial chemoembolization alone in patients with unresectable hepatocellular carcinoma: A retrospective study.

被引：0

作者：

Guo, Wenbo ^{[1
]}

Chen, Song ^{[1
]}

机构：

[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol Intervent, Guangzhou, Peoples R China

来源：

关键词：

Hepatocellular carcinoma; Anlotinib; Transarterial chemoembolization;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e16611

引用

页数：1